MARIZA OLIVER: Open Payments
NPI 1477969848 · BROWNSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,240 in 55 payments from 31 companies in 2025. Trend: 2023 $1,974 · 2024 $2,129 · 2025 $2,240
Food & beverage: $2,140Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $327 |
| E.R. Squibb & Sons, L.L.C. | 4 | $173 |
| Eisai Inc. | 2 | $146 |
| Exelixis Inc. | 2 | $139 |
| AstraZeneca Pharmaceuticals LP | 2 | $126 |
| Tempus AI, Inc | 1 | $126 |
| Stemline Therapeutics Inc. | 1 | $125 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $123 |
| Incyte Corporation | 1 | $100 |
Products named: RYBREVANT, Lenvima, CABOMETYX, XT CDX, Orserdu, ZYNLONTA, POTELIGEO, Enhertu.
Industry payments across TX — which companies pay providers there.
